Event Date
Thu 21 May 2020 15:00

This event will be held online via webinar. You will receive the webinar link after you register. 

This webinar will describe participants in the N-ICE trial, a recently completed pharmacotherapy trial for methamphetamine dependence.

The N-ICE trial is a randomised controlled trial of N-Acetyl Cysteine (NAC) for methamphetamine (“ice”) dependence. Through this recently completed trial we were able to recruit and follow-up a sizable cohort of people who wanted to reduce their methamphetamine use, many of whom had not previously received treatment, and the majority of whom smoked crystalline methamphetamine.
This seminar will detail the demographic and drug use characteristics of participants randomised into the trial, provide a taste of other trial data (including medication adherence data collected using eCAPTM technology), and discuss some of the challenges and successes in carrying out the trial.

Speaker Bio:
Associate Professor Rebecca McKetin
National Drug and Alcohol Research Centre, UNSW

A/Prof McKetin (BSc(Psychol)Hons. PhD) has a background in psychology and public health. She leads a program of research into stimulant use epidemiology and interventions at the National Drug and Alcohol Research Centre, University of New South Wales. She has published over 170 research articles in this area and her current work includes developing and trialling new treatment approaches for stimulant use, including online self-help and new medications. She led the recently completed N-ICE trial, the largest pharmacotherapy trial for methamphetamine use to have been conducted in Australia, which she will discuss in her presentation.

Location
This event will be held online via webinar. You will receive the webinar link after you register.

Contact
NDARC.Events@unsw.edu.au